 | |
- close
- close
StreetInsider.com
Feb 8
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Lannett+%28LCI%29+reports+Breakeven+Q2+Earnings%2C+Misses+by+4c/5319265.html for the full story.
Business Wire
Feb 8
Comment
Lannett Company, Inc. (NYSE AMEX: LCI) today reported financial results for the fiscal 2010 second quarter and six months ended December 31, 2009. For the second quarter of fiscal 2010, net sales were $28.7 million, compared with $29.2 million for
Business Wire
Feb 3
Comment
Lannett Company, Inc. (NYSE Amex: LCI), a manufacturer of generic pharmaceuticals, today announced that the company will release its fiscal 2010 second-quarter financial results on Monday, February 8, 2010. Lannett management will host a conference
Business Wire
Feb 2
Comment
Lannett Company, Inc. (NYSE AMEX: LCI) today announced plans to submit its New Drug Application (NDA) for its Morphine Sulfate products to the U.S. Food and Drug Administration (FDA) at the end of the month. The company expects the FDA to review its
Business Times - Malaysia
Dec 29
Comment
LCI Global Sdn Bhd, a wholly-owned subsidiary of Linear Corporation Bhd, has been awarded a contract worth RM1.66 billion by Global Investment Group Inc.
The contract is for design, construction, completion and commissioning of a...
StreetInsider.com
Dec 10
Comment
Visit StreetInsider.com at http://www.streetinsider.com/FDA/Lannett+%28LCI%29+Receives+FDA+Approval+for+Generic+Dilaudid/5175448.html for the full story.
Business Wire
Dec 10
Comment
Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has received approvals from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Applications (ANDAs) for Hydromorphone Hydrochloride Tablets USP, 2 mg, 4 mg and 8 mg,
newratings.com
Dec 3
Comment
NEW YORK, December 3 (newratings.com) - Analysts at Roth Capital reinitiate coverage of Lannett (ticker: LCI) with a "buy" rating. The target price is set to $8.5. [more]
StreetInsider.com
Nov 20
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Stock+Buybacks/Lannett+%28LCI%29+Reauthorizes+%245M+Buyback/5130479.html for the full story.
Business Wire
Nov 20
Comment
Lannett Company, Inc. (NYSE AMEX: LCI) today announced that its Board of Directors has approved a reauthorization of the stock repurchase program. Under the program, the company is authorized to repurchase up to $5 million of Lannett’s outstanding
Suggest other news sources for this topic
Thank you for your suggestion
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| ||||||
